Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioNTech SE (DE:22UA)
XETRA:22UA
Holding DE:22UA?
Track your performance easily
See the Price Targets and Ratings of:
22UA Analyst Ratings
Strong Buy
13 Buy
4 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
22UA Stock 12 Month Forecast
Average Price Target
€136.10
▲(25.44% Upside)
| Highest Price Target€165.42 | Average Price Target€136.10 | Lowest Price Target€117.71 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Morgan Stanley
Reiterated
12/23/24
Jefferies
Reiterated
12/19/24
Leerink Partners
Reiterated
12/18/24
J.P. Morgan
Reiterated
12/17/24
Wells Fargo
Initiated
12/11/24
TD Cowen
Reiterated
12/03/24
BMO Capital
Reiterated
12/01/24
Deutsche Bank
Reiterated
11/27/24
Canaccord Genuity
Reiterated
11/27/24
Goldman Sachs
Reiterated
11/26/24
Evercore ISI
€106.14→€120.61
Buy
11.16%
Upside
Upgraded
11/19/24
BioNTech upgraded to Outperform from In Line at Evercore ISIBioNTech upgraded to Outperform from In Line at Evercore ISI
Berenberg Bank
€125.43
Buy
15.61%
Upside
Initiated
11/18/24
Positive Report for BioNTech SE (BNTX) from Berenberg Bank
H.C. Wainwright
€144.73
Buy
33.39%
Upside
Reiterated
11/18/24
BioNTech's Strategic Acquisition of Biotheus Bolsters Oncology Portfolio and Justifies Buy Rating
Bank of America Securities
€144.73
Buy
33.39%
Upside
Reiterated
11/15/24
BioNTech SE: Strong Oncology Pipeline and Financial Position Offset Vaccine Business Uncertainty
Best Analysts Covering BioNTech SE
Which Analyst Should I Follow If I Want to Buy DE:22UA and Sell After:
1 Month
xxx
Success Rate
5/9 ratings generated profit
Average Return
+4.43%
reiterated a xxx
rating 8 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 55.56% of your transactions generating a profit, with an average return of +4.43% per trade.
3 Months
xxx
Success Rate
7/18 ratings generated profit
Average Return
+2.67%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 38.89% of your transactions generating a profit, with an average return of +2.67% per trade.
1 Year
Success Rate
7/8 ratings generated profit
Average Return
+20.90%
reiterated a buy rating 23 days ago
Copying Etzer Darout's trades and holding each position for 1 Year would result in 87.50% of your transactions generating a profit, with an average return of +20.90% per trade.
2 Years
xxx
Success Rate
13/18 ratings generated profit
Average Return
+39.85%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 72.22% of your transactions generating a profit, with an average return of +39.85% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
22UA Analyst Recommendation Trends
Rating
Aug 24
Sep 24
Oct 24
Nov 24
Dec 24
Strong Buy
7
4
3
5
4
Buy
13
14
20
38
40
Hold
19
22
20
16
13
Sell
4
3
3
1
0
Strong Sell
0
0
0
0
0
total
43
43
46
60
57
Each month's total comprises the sum of three months' worth of ratings.
22UA Financial Forecast
22UA Stock Forecast FAQ
What is DE:22UA’s average 12-month price target, according to analysts?
Based on analyst ratings, BioNTech SE’s 12-month average price target is €136.10.
What is DE:22UA’s upside potential, based on the analysts’ average price target?
BioNTech SE has 25.44% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is BioNTech SE a Buy, Sell or Hold?
BioNTech SE has a consensus rating of Strong Buy, which is based on 13 buy ratings, 4 hold ratings and 0 sell ratings.
What is BioNTech SE’s share price target?
The average share price target for BioNTech SE is €136.10. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €165.42 ,and the lowest forecast is €117.71. The average share price target represents 25.44% Increase from the current price of €108.5.
The highest analyst share price target is €165.42 ,and the lowest forecast is €117.71. The average share price target represents 25.44% Increase from the current price of €108.5.
What do analysts say about BioNTech SE?
BioNTech SE’s analyst rating consensus is a Strong Buy. This is based on the ratings of 17 Wall Streets Analysts.
How can I buy shares of BioNTech SE?
To buy shares of DE:22UA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.